Accuracy of Case-Based Seroprevalence of SARS-CoV-2 Antibodies in Maricopa County, Arizona
Year: 2021
Type: article
Study design: Observational Study
Abstract: We conducted a community seroprevalence survey in Arizona, from September 12 to October 1, 2020, to determine the presence of antibodies to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). We used the seroprevalence estimate to predict SARS-CoV-2 infections in the jurisdiction by applying the adjusted seroprevalence to the county’s population. The estimated community seroprevalence of SARS-CoV-2 infections was 4.3 times greater (95% confidence interval = 2.2, 7.5) than the number of reported cases. Field surveys with representative sampling provide data that may help fill in gaps in traditional public health reporting. (Am J Public Health. 2022;112(1):38–42. https://doi.org/10.2105/AJPH.2021.306568 )
Authors: Megan Jehn, Urvashi Pandit, Susanna Sabin, Camila Tompkins, Jessica White, Erin Kaleta, Ariella P. Dale, Heather M. Ross, J. Mac McCullough, Susan Pepin, Katherine Kenny, Heidi Sanborn, Natalie Heywood, Amy H. Schnall, Timothy Lant, Rebecca Sunenshine
Language: English
Subfield: Infectious Diseases
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W4200509448